Showing 721-730 of 9663 results for "".
EHR User Series: Part I
https://practicaldermatology.com/topics/practice-management/ehr-user-series-part-i/22966/A Q&A series with users of EHR technology about their own experience and their broader impressions of EHR in dermatology.Skin Resurfacing, Pixel RF from Alma Lasers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/-skin-resurfacing-pixel-rf-from-alma-lasers/19241/Skin resurfacing with the innovative Pixel RF from Alma Lasers. Ready to fight the hands of time? Click here for more info: http://www.AlmaLasers.comFrom Clinic to Capitol: Tips for Building Grassroots and Legislative Support For Anti-Tanning Policies in Your State
https://practicaldermatology.com/topics/skin-cancer-photoprotection/from-clinic-to-capitol-tips-for-building-grassroots-and-legislative-support-for-anti-tanning-policies-in-your-state/22943/It's no easy task to shepherd legislation through state assemblies, but dermatologists' clinical standing can have some influence.The Big Idea: Jeanine Downie, MD on Purchasing Her Own Space
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-purchasing-her-own-space/19278/Dr. Downie explains why she wanted her own space and describes the major and minor benefits of ownership, including cost savings. Featured in "What's The Big Idea"Support for Population- Based Skin Cancer Screenings
https://practicaldermatology.com/topics/skin-cancer-photoprotection/support-for-population--based-skin-cancer-screenings/21675/A new study offers data to show that general skin cancer screenings by dermatologists and properly trained physicians can reduce morbidity and mortality.Sunscreen Labeling
https://practicaldermatology.com/topics/practice-management/sunscreen-labeling-/19370/Neal Bhatia, MD discusses the impact of new sunscreen labeling on patient education, as well as strategies for UV avoidance, and trends in therapeutic development.Psoriasis Pipeline Update: JNJ-2113, A Novel Oral IL-23 Receptor Antagonist Peptide, Shows Promise in a Phase 2b Study
https://practicaldermatology.com/topics/psoriasis/psoriasis-pipeline-update-jnj-2113-a-novel-oral-il-23-receptor-antagonist-peptide-shows-promise-in-a-phase-2b-study/20207/Laura Korb Ferris, MD, PhD, discusses the topline results from a Phase 2b trial of JNJ-2113, a novel oral IL-23 receptor antagonist peptide that’s being developed for moderate-to-severe plaque psoriasis.Dispatches from the 2022 Skin of Color Update
https://practicaldermatology.com/conferences/skin-of-color-update-2022/dispatches-from-the-2022-skin-of-color-update/23822/Co-chair Dr. Andrew F. Alexis shares highlights from the recent meeting.Success Factors in Selling A Dermatology Practice
https://practicaldermatology.com/topics/practice-management/success-factors-in-selling-a-dermatology-practice/23499/What to do if you’re considering a sale or merger.“No-touch” Surgical Excision & “Double-freeze-thaw” Cryotherapy Techniques
https://practicaldermatology.com/topics/skin-cancer-photoprotection/conjunctival-scc/19861/A 68-year-old white male with a history of basal cell carcinoma of the right lower eyelid, surgically excised 10 years prior to presentation, was referred to the Ocular Oncology Service at Wills Eye Hospital, Philadelphia for an asymptomatic conjunctival lesion on the right eye. The patient was trea